Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey.

Lenzen MJ, Scholte op Reimer WJ, Boersma E, Vantrimpont PJ, Follath F, Swedberg K, Cleland J, Komajda M.

Eur Heart J. 2004 Jul;25(14):1214-20.

PMID:
15246639
2.

The importance of heart rate recovery in patients with heart failure or left ventricular systolic dysfunction.

Lipinski MJ, Vetrovec GW, Gorelik D, Froelicher VF.

J Card Fail. 2005 Oct;11(8):624-30.

PMID:
16230267
3.

[Differences in clinical profile and outcome in patients with decompensated heart failure and systolic dysfunction or preserved systolic function].

Macín SM, Perna ER, Címbaro Canella JP, Alvarenga P, Pantich R, Ríos N, Farías EF, Badaracco JR.

Rev Esp Cardiol. 2004 Jan;57(1):45-52. Spanish.

4.

Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.

Fonarow GC, Stough WG, Abraham WT, Albert NM, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB; OPTIMIZE-HF Investigators and Hospitals.

J Am Coll Cardiol. 2007 Aug 21;50(8):768-77. Epub 2007 Aug 6.

5.

[Clinical characteristics and medium-term prognosis of patients with heart failure and preserved systolic function. Do they differ in systolic dysfunction?].

Ojeda S, Anguita M, Muñoz JF, Rodríguez MT, Mesa D, Franco M, Ureña I, Vallés F.

Rev Esp Cardiol. 2003 Nov;56(11):1050-6. Spanish.

6.
7.
8.

Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database.

Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC; ADHERE Scientific Advisory Committee and Investigators.

J Am Coll Cardiol. 2006 Jan 3;47(1):76-84. Epub 2005 Dec 15. Erratum in: J Am Coll Cardiol. 2006 Apr 7;47(7):1502.

9.

The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis.

Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, Dietz R, Gavazzi A, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, van Gilst WH, Widimsky J, Freemantle N, Eastaugh J, Mason J; Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology.

Eur Heart J. 2003 Mar;24(5):442-63.

PMID:
12633546
10.

Management of patients with heart failure in clinical practice: differences between men and women.

Lenzen MJ, Rosengren A, Scholte op Reimer WJ, Follath F, Boersma E, Simoons ML, Cleland JG, Komajda M.

Heart. 2008 Mar;94(3):e10. Epub 2007 Jun 17.

PMID:
17575332
11.

Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function.

Gustafsson F, Torp-Pedersen C, Brendorp B, Seibaek M, Burchardt H, Køber L; DIAMOND Study Group.

Eur Heart J. 2003 May;24(9):863-70.

PMID:
12727154
12.

Anemia in patients with heart failure and preserved systolic function.

Felker GM, Shaw LK, Stough WG, O'Connor CM.

Am Heart J. 2006 Feb;151(2):457-62.

PMID:
16442914
13.

Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials.

Ezekowitz JA, McAlister FA.

Eur Heart J. 2009 Feb;30(4):469-77. doi: 10.1093/eurheartj/ehn543. Epub 2008 Dec 9. Review.

PMID:
19066207
14.

[Clinical outcome and reversibility of systolic dysfunction in patients with dilated cardiomyopathy due to hypertension and chronic heart failure].

Anguita Sánchez M, Rodríguez Esteban M, Ojeda Pineda S, Ruiz Ortiz M, Romo Peña E, Mesa Rubio D, Vallés Belsué F.

Rev Esp Cardiol. 2004 Sep;57(9):834-41. Spanish.

15.

Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).

White HD, Aylward PE, Huang Z, Dalby AJ, Weaver WD, Barvik S, Marin-Neto JA, Murin J, Nordlander RO, van Gilst WH, Zannad F, McMurray JJ, Califf RM, Pfeffer MA; VALIANT Investigators.

Circulation. 2005 Nov 29;112(22):3391-9. Epub 2005 Nov 21.

16.

Outcomes by race and etiology of patients with left ventricular systolic dysfunction.

Thomas KL, East MA, Velazquez EJ, Tuttle RH, Shaw LK, O'Connor CM, Peterson ED.

Am J Cardiol. 2005 Oct 1;96(7):956-63.

PMID:
16188524
17.

ACE inhibitors in heart failure: what more do we need to know?

Demers C, Mody A, Teo KK, McKelvie RS.

Am J Cardiovasc Drugs. 2005;5(6):351-9. Review.

PMID:
16259523
18.

An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry.

Velazquez EJ, Francis GS, Armstrong PW, Aylward PE, Diaz R, O'Connor CM, White HD, Henis M, Rittenhouse LM, Kilaru R, van Gilst W, Ertl G, Maggioni AP, Spac J, Weaver WD, Rouleau JL, McMurray JJ, Pfeffer MA, Califf RM; VALIANT registry.

Eur Heart J. 2004 Nov;25(21):1911-9.

PMID:
15522470
19.

Clinical outcome of patients with heart failure and preserved left ventricular function.

Gotsman I, Zwas D, Planer D, Azaz-Livshits T, Admon D, Lotan C, Keren A.

Am J Med. 2008 Nov;121(11):997-1001. doi: 10.1016/j.amjmed.2008.06.031.

PMID:
18954847
20.

Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or both.

Prisant LM, Thomas KL, Lewis EF, Huang Z, Francis GS, Weaver WD, Pfeffer MA, McMurray JJ, Califf RM, Velazquez EJ.

J Am Coll Cardiol. 2008 May 13;51(19):1865-71. doi: 10.1016/j.jacc.2007.12.050.

Supplemental Content

Support Center